COMMENTARY

Reducing tobacco addiction through tobacco product regulation

J E Henningfield¹, N L Benowitz², G N Connolly³, R M Davis⁴, N Gray⁵, M L Myers⁶ and M Zeller⁷

¹ Pinney Associates Inc, Bethesda, Maryland, USA and Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
² University of California San Francisco, San Francisco, California, USA
³ Harvard University School of Public Health, Boston, Massachusetts, USA
⁴ Henry Ford Health System, Detroit, Michigan, USA
⁵ International Agency for Research on Cancer, Lyon, France
⁶ Campaign for Tobacco-Free Kids, Washington, DC, USA
⁷ Pinney Associates, Inc, Bethesda, Maryland, USA

Correspondence to:
Correspondence to:
Jack E Henningfield PhD
Pinney Associates, Inc, 4800 Montgomery Lane, Suite 1000, Bethesda, MD 20814, USA; jhenning{at}pinneyassociates.com

Tobacco product regulation has the potential to help reduce tobacco attributable disease by reducing the toxicity of these products and by reducing the prevalence of tobacco use and addiction

Abbreviations: FCTC, Framework Convention on Tobacco Control; FDA, Food and Drug Administration; FTC, Federal Trade Commission; ISO, International Organization for Standardization

Keywords: addiction; harm reduction; ingredient; regulation

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kreslake, J. M., Wayne, G. F., Alpert, H. R., Koh, H. K., Connolly, G. N. (2008). Tobacco Industry Control of Menthol in Cigarettes and Targeting of Adolescents and Young Adults. Am. J. Public Health 98: 1685-1692 [Abstract] [Full Text]  
• Koop, C. E. (2007). Health and Health Care for the 21st Century: For All the People. The Oncologist 12: 366-369 [Full Text]  
• Koop, C. E. (2006). Health and Health Care for the 21st Century: For All the People. Am. J. Public Health 96: 2090-2092 [Full Text]  
• Henningfield, J. E, Rose, C. A, Zeller, M. (2006). Tobacco industry litigation position on addiction: continued dependence on past views. Tobacco Control 15: iv27-iv36 [Abstract] [Full Text]  
• Pletcher, M. J., Hulley, B. J., Houston, T., Kiefe, C. I., Benowitz, N., Sidney, S. (2006). Menthol Cigarettes, Smoking Cessation, Atherosclerosis, and Pulmonary Function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.. Arch Intern Med 166: 1915-1922 [Abstract] [Full Text]  
• Ferris Wayne, G, Connolly, G N, Henningfield, J E (2006). Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents. Tobacco Control 15: 189-198 [Abstract] [Full Text]  
• Lewis, M. J., Wackowski, O. (2006). Dealing With an Innovative Industry: A Look at Flavored Cigarettes Promoted by Mainstream Brands. Am. J. Public Health 96: 244-251 [Abstract] [Full Text]  
• Gray, N, Henningfield, J E, Benowitz, N L, Connolly, G N, Dresler, C, Fagerstrom, K, Jarvis, M J, Boyle, P (2005). Toward a comprehensive long term nicotine policy. Tobacco Control 14: 161-165 [Abstract] [Full Text]  
• Mazzone, P. J., Arroliga, A. C. (2004). How Many Ways Can We Say That Cigarette Smoking Is Bad for You?. Chest 126: 1717-1718 [Full Text]  

eLetters:

Read all eLetters

How do you know this wont make things even worse? (updated)

Clive Bates

Tobacco Control Online, 24 Jul 2004 [Full text]